Document is current
Any future updates will be listed below
-
Authors
Liapis, Konstantinos https://orcid.org/0000-0003-1165-9639
Papadopoulos, Vasileios https://orcid.org/0000-0002-4188-9518
Vrachiolias, George
Galanopoulos, Athanasios G.
Papoutselis, Menelaos
Papageorgiou, Sotirios G.
Diamantopoulos, Panagiotis T.
Pappa, Vassiliki
Viniou, Nora-Athina
Kourakli, Alexandra
Ī¤sokanas, Dimitris
Vassilakopoulos, Theodoros P.
Hatzimichael, Eleftheria https://orcid.org/0000-0002-4408-5646
Bouronikou, Eleni
Ximeri, Maria
Pontikoglou, Charalambos
Megalakaki, Aekaterini
Zikos, Panagiotis
Panayiotidis, Panayiotis
Dimou, Maria https://orcid.org/0000-0001-8197-9895
Karakatsanis, Stamatis https://orcid.org/0000-0003-1793-6617
Papaioannou, Maria
Vardi, Anna
Kontopidou, Flora
Harchalakis, Nikolaos
Adamopoulos, Ioannis
Symeonidis, Argiris https://orcid.org/0000-0002-3685-3473
Kotsianidis, Ioannis
- License Information
-
More Information
Article History
Received: 24 September 2020
Accepted: 20 January 2021
First Online: 11 February 2021
Originality statement
: This manuscript contains original material that has not been published or submitted previously to another journal. All authors agree to the submission of this manuscript to the Blood Cancer Journal.
: This study was approved by the Ethics Committee of the Hellenic Society of Haematology (Protocol: No.8/26-3-2008). This study was done in accordance with the ethical standards of the Institutional Research Committees of the participating centers, and in compliance with the ethical principles of the Declaration of Helsinki.
: The basis for this study formed the database of the Hellenic National Registry of Myelodysplastic and Hypoplastic Syndromes, under the auspices of the Hellenic Society of Haematology. All clinical samples and data were collected during routine patient care. This study was approved by the Ethics Committee of the Hellenic Society of Haematology (Protocol: No.8/26-3-2008).
: I.K., N.A.V., A.S., E.H. and Vasiliki Pappa have received research funding from Celgene Corporation (of no relevance to this study). I.K., S.G.P., T.P.V., A.G.G., E.H., P.P., A.K., A.S., Vasiliki Pappa, and N.A.V. have received honoraria from Genesis Pharma Hellas S.A. (of no relevance to this study). All other authors have no conflicts of interest.
